Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase
Related Experiment Video
Updated: Sep 26, 2026

2D and 3D Matrices to Study Linear Invadosome Formation and Activity
Published on: June 2, 2017
Takahisa Takino1, Hisashi Miyamori, Noriko Kawaguchi
1Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, 920-0934, Kanazawa, Japan.
Abstract:
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is known to be internalized from cell surface, however, the fate of internalized MT1-MMP is still unknown. Here we demonstrate that at least a part of internalized MT1-MMP is targeted for lysosomal proteolysis. Treatment with an inhibitor of lysosomal proteinases chloroquine suppressed degradation of internalized MT1-MMP and induced accumulation of MT1-MMP in CD63-positive lysosomes. Ectopic expression of CD63 accelerated degradation of MT1-MMP, which was blocked by chloroquine. MT1-MMP, and CD63 were shown to form a complex through hemopexin-like domain of MT1-MMP and N-terminal region of CD63, and thus accelerated degradation of MT1-MMP was not observed with mutants lacking these domains. CD63 mutant lacking lysosomal targeting motif was unable to promote MT1-MMP degradation. These results suggest that CD63 regulates MT1-MMP by targeting to lysosomes.
Insights
Internalized membrane-type 1 matrix metalloproteinase (MT1-MMP) is degraded in lysosomes. CD63 protein facilitates this process by targeting MT1-MMP for lysosomal proteolysis, revealing a novel regulatory pathway.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Membrane-type 1 matrix metalloproteinase (MT1-MMP) undergoes internalization from the cell surface.
- The degradation pathway and ultimate fate of internalized MT1-MMP remain largely uncharacterized.
Purpose of the Study:
- To elucidate the degradation mechanism of internalized MT1-MMP.
- To investigate the role of CD63 in the cellular trafficking and degradation of MT1-MMP.
Main Methods:
- Treatment with lysosomal protease inhibitor (chloroquine).
- Ectopic expression of CD63 and its mutants.
- Co-immunoprecipitation to assess protein complex formation.
- Analysis of MT1-MMP localization in CD63-positive lysosomes.
Main Results:
- Chloroquine treatment inhibited MT1-MMP degradation and caused its accumulation in CD63-positive lysosomes.
- Ectopic CD63 expression accelerated MT1-MMP degradation, an effect blocked by chloroquine.
- MT1-MMP and CD63 form a complex via MT1-MMP's hemopexin-like domain and CD63's N-terminal region.
- A CD63 mutant lacking a lysosomal targeting motif failed to enhance MT1-MMP degradation.
Conclusions:
- Internalized MT1-MMP is targeted for lysosomal degradation.
- CD63 plays a crucial role in regulating MT1-MMP levels by mediating its lysosomal targeting and proteolysis.
- The interaction between MT1-MMP and CD63 is essential for this degradation pathway.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Overview of Cell-Matrix Interactions
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Intracellular Signaling Affects Focal Adhesions
Some...
Golgi Matrix Proteins
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...

